Accepted Articles                   Back to the articles list | Back to browse issues page

XML Print

1- Shiraz University of Medical Sciences
2- Iran University of Medical Sciences
3- Kerman University of Medical Sciences
Primary Diffuse Large B Cell Lymphoma of CNS (PCNSL) is a rare variant of Diffuse Large B Cell Lymphoma (DLBCL) and presents with an aggressive clinical course and usually resistant to commonly used therapy regimens. Recently, role of immune checkpoint molecules including PD-1 and PD-L1 confirmed in some solid tumors and lymphoma resulting tumor cells escape the immune system and help to survive and to spread. Inhibitors of PD-1 and PD-L1 have shown lasting responses in several solid and some hematological tumors, while limited studies evaluate checkpoint molecules on PCNSL. In this study, we investigated PD-1 and PD-L1 expression by immunostaining on 71 patients with PCNSL and correlation with demographic data, location of the tumor, proliferation rate, cell of origin, and CD8 positive T cell infiltration in tumor microenvironment. No association was determined between PD-1/PD-L1 expression and gender, cell of origin, and proliferation rate, but a highly significant difference was determined between the infiltration of CD8 positive T cells in two groups of PD-1/PD-L1 positive and negative.
Type of Study: Original | Subject: Clinical Neuroscience
Received: 2020/05/5 | Accepted: 2020/05/17

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb